Publication changelog
Research Updates
What changes in this library and when: new evidence, revised regulatory status, and pages that have been re-checked against their primary sources.
This is not a waitlist. This page tracks changes to our published research. It is not a queue for any compound, not a sign-up for treatment, and not an indication that any compound discussed in this library will become available. Nothing in this section offers access to anything.
Most recently reviewed
- CJC-1295: Research, FDA Status & What We KnowReviewed September 14, 2026
- ENDO-205: A New Way of Thinking About EndometriosisReviewed September 14, 2026
- Ipamorelin: Research, FDA Status & What We KnowReviewed September 14, 2026
- PEG-MGF: Muscle-Recovery Claims vs. Human EvidenceReviewed September 12, 2026
- Sermorelin: Sleep, Recovery & Growth Hormone ResearchReviewed September 12, 2026
- Tesamorelin: Visceral Fat, FDA Status & What the Evidence ShowsReviewed September 12, 2026
- Dihexa: Research, FDA Status & What We KnowReviewed September 11, 2026
- LL-37: The Human “First-Line Defense” PeptideReviewed September 11, 2026
Want to hear when something changes?
An email list for this library is not open yet. When it is, it will carry one thing: notice that a research page has been added or its regulatory position has changed. Until then, contact us if you want to be told when a specific page is updated.